• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • EA Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • EA Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Stay Updated
  • We’re hiring!

Weill Cornell Medical College — COVID-19 Antiviral Studies (Ria Goswami)

Visit Grantee Site
  • Focus Area: Scientific Research
  • Organization Name: Weill Cornell Medical College
  • Amount: $220,553

  • Award Date: February 2021

Table of Contents

    Grant Investigators: Heather Youngs and Chris Somerville

    This page was reviewed but not written by the grant investigators. Weill Cornell Medical College staff also reviewed this page prior to publication.

    Open Philanthropy recommended a grant of $220,553 to the Weill Cornell Medical College of Cornell University to enable postdoctoral researcher Ria Goswami and Dr. Sallie Permar to collaborate with researchers at Duke University and UC Davis to study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus.

    This follows our May 2020 support for earlier phases of the study at Duke University and falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.

    Related Items

    • Scientific Research

      Botswana-Harvard AIDS Institute – Early detection of preterm births

      Image courtesy of Botswana-Harvard AIDS Institute Open Philanthropy recommended a grant of $90,000 to the Botswana–Harvard AIDS Institute to support an NIH-funded study led by Dr. Jeff...

      Read more
    • Scientific Research

      University Of Science Technical And Technologies De Bamako — Malaria Vaccine Clinical Trial (Alassane Dicko)

      Open Philanthropy recommended a grant of $630,123 over three years to the University Of Science Technical And Technologies De Bamako to participate in a phase III clinical trial...

      Read more
    • Scientific Research

      Institut des Sciences et Techniques, Bobo-Dioulasso — Malaria Vaccine Clinical Trial (Jean Bosco Ouedraogo)

      Open Philanthropy recommended a grant of $631,162 over three years to the Institut des Sciences et Techniques, Bobo-Dioulasso to participate in a phase III clinical trial of a...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    Mailing Address
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    Sign Up to Follow Our Work

    Join Our Mailing List

    © Open Philanthropy 2022